Upload
others
View
3
Download
0
Embed Size (px)
Citation preview
April 12th 2018
To Cut or Not to Cut?
What is the Role of Surgery in the
management of pediatric Lung Lesions
Canadian Respiratory Conference: A breath of fresh air
Sarah Bouchard,
MDCM, FRCSC, FACS
Associate professor of Surgery
University of Montreal
Financial Interest Disclosure(over the past 24 months)
Dr. Sarah Bouchard
I have no conflict of interest.
Prenatal diagnosis of lung lesions Natural history & exclusion
of other anomalies
Serial ultrasounds
MRI
Karyotype
Pathophysiology survival
Monitoring of size & effect
Treatment plan based on prognosis
Postnatal therapy planned & coordinated
Prenatal treatment
?
Classification of Congenital Lung Lesions, Langston C, 2003
Bronchopulmonary malformation Bronchogenic cyst
Bronchial atresia
Congenital pulmonary airway malformation (Stocker type 1 and 2) (most common: 0.66 /10 000)
Bronchopulmonary sequestration (10%)
Pulmonary hyperplasia and related lesions Laryngeal atresia
Congenital pulmonary airway malformation (Stocker type 3)
Polyalveolar lobe
Congenital lobar emphysema
Other cystic lesions Lymphatic/lymphangiomatous cysts
Enteric cysts
Mesothelial cysts
Simple parenchymal cysts
Low-grade cystic pleuropulmonary blastoma
Bronchopulmonary sequestration Non-functionning lung mass
Systemic blood supply
Rarely produces symptoms antenatally,
except massive pleural effusion.
Can be associated with congenital
diaphragmatic hernia, or Scimitar
syndrome
Can represent hybrid lesions
Intralobar are more common (75–85%)
and usually present later in life with
recurrent infections
As pediatric surgeons we tend to see
extralobar sequestration more often.
Congenital pulmonary airway malformation (CPAM)
CCAM prevalence 0.66 / 10 000
Associated anomalies in up to 20%
Only 25% symptomatic at birth
CPAM classification Stocker classification
Type 0: Solid appearance
Type 1: large cyst, multiloculated, > 2 cm
Type 2: small cyst < 2 cm
Type 3: solid (microcystic)
Type 4: Very large cyst
Type I and II could be isolated or
hybrid (intralobar sequestration)
Prenatal:1. Macrocystic: cyst 5mm in diam or
larger
2. Microcystic: solid echogenic mass
Overall prognosis depends on
size rather than type of lesion
Congenital lung lesionsRegression: 20% CPAM
> 2/3 Sequestration
Compression:
Esophagus Polyhydramnios
Lung Hypoplasia
Inferior Hydrops Mortality
vena cava or
Hydrothorax
Prenatal surveillance: CPAM VOLUME RATIOCrombelhome T, et al., J Pediatr Surg, March 2002
0.52 x Lenght x Height x Width
Head circumference
< 1.6 (n=42): hydrops in 7 pts (16.7%); 6 with main cyst
> 1.6 (n=16): hydrops in 12 pts (75%)
1.6 : risk of hydrops F/U 2x/week
1.2 – 1.6 2x/week initially, then weekly
1.2 weekly initially, then q 2 weeks
Prenatal natural history of CPAM
• Growth plateau at around 30
weeks
• Rarely regresses, but stabilizes
in size, thus seems smaller given
continued fetal growth
Pathophysiology of large fetal lung lesions
• Esophageal compression
• interference with swallowing of amniotic fluids
• Polyhydramnios
• Cysts hyperinflation from liquid trapping
• Vena caval obstruction + cardiac compression
• extreme mediastinal shift
• Hydrops
• Placentomegaly
• Fetal demise
Adzick NS, et al., Seminars in Pediatric Surgery, February 2003
Prenatal management if hydrops
• Steroids administration
• Pleuroamniotic shunts
• Fetal lobectomy
• If maternal mirror syndrome? Pregnancy termination
< 32 weeks
• Delivery with postnatal management> 32 weeks
Variable response to steroids in high risk lesions (Cincinnati)
15 patients treated
13 hydropic fetuses responded initially
7/15 patients resulted in fetal demise or postnatal death
Overall survival rate 53%
Second course of steroids was not helpful
Consider shunting and/or open fetal surgery in non-responder
Morris et al, JPS 2009; 44:60-65
Best delivery mode for fetuses
with large lung lesions causing
mediastinal shift and
polyhydramnsios?
EXIT
EX utero Intrapartum Treatment
Risks:
Hypoventilation
from lack of space
Hypoxia
Acidosis
EXIT C-section
Minimal anesthesia
time:
Fetal exposure
Newborn respiratory
depression
Low anesthetics MAC
Preserve uterus tone
Prevent maternal
hemorhage
C-section
Fetal anesthesia and analgesia desired
Deep anesthesia
Uterine relaxation
Risk of maternal
hemorrhage
EXIT
Resection of symptomatic CPAM
Acute respiratory distress 1/3 neonates prenatally diagnosed
No arguments! Next slide!
Open approach
If less than 5 kilos
Cannot tolerate one lung ventilation during general anesthesia
Lesion too large to allow access and safe dissection via
thoracoscopy
Otherwiswe thoracoscopy can be attempted
Presentation from childhood to adulthood
60% Symptoms < 1 mo
10% Symptoms 1 to 6 mo
15% Symptoms 6 mo to 14 years ( risk cancer)
97% Dx < 1 an
Symptoms: Recurrent respiratory infections
Dyspnea
Hemoptysis
Hemothorax
Empyema
Pneumothorax
Malignant transformation
Incidental finding
Imaging studies: asymptomatic
patient Usefulness of CXR?
Baseline
Allows for follow-up if lesion is visible
Timing of thoracic CT scan
Wait for clearance of lung fluid
2 to 6 months
Other – MRI – less radiation for follow up
Barium swallow – differentiation from CDH
9 month old healthy baby boy, with
extralobar sequestration as seen on
previous slide.
Asymptomatic
Resection or no resection?
Approach?
Vignette
Treatment of extralobar sequestration
sequestration Resection
Wait for sufficient size to allow thoracoscopy if patient
asymtomatic (6 months)
Thoracoscopic approach preferred
Embolisation reported but
Pain
Fever
Tissue never really disappear
Not a definitive treatment
Resection of intralobar sequestration
If no symtpoms it will depends on size
Reluctance to remove a “functioning” lobe
For symptomatic patient a lobectomy will be
performed
Preferably via thoracoscopy
Postnatal surgical management of lung
anomalies in asymptomatic patients
«To doubt everything or to believe everything are
equally easy solutions, for both protect us from
thinking»
(Poincaré)
Arguments for routine resection of asymptomatic CPAM
Long-term risk of infection
Some argue that the surgical risk is higher if the lesion has
already been infected (not all studies have documented this
difference).
Early resection results in better compensatory lung growth
Hypothetical advantage which is not universally supported in long-
term follow-up studies
Possibility that the lesion is not a benign CPAM, but is instead a
Type I pleuropulmonary blastoma (PPB).
Risk of Infection
Risk of infection
10% to 30%of CPAM will present with infection
10% per year, so cumulative incidence
May have higher rate of complication if surgery performed after an
episode of infection
Higher loss of productive time for patient and parent
Risk of malignancy
Really?
Multitude of reported cases and registries
Difficult to differentiate between CPAM and PBS
Broncho alveolar Carcinoma
Rhabdomyosarcoma
Epidermoid carcinoma
Mucinous adenocarcinoma
Can congenital pulmonary airway malformation be distinguished from Type I
pleuropulmonary blastoma based on clinical and radiological features?Journal of Pediatric Surgery , Volume 51, Issue 1, Pages 33-37 (January 2016)
Decision-Making Criteria for Observational Management of
Congenital Pulmonary Airway Malformations (CPAMs)
Number of lesions,
Presence of a solid component
Size of the cysts.
This said, these criteria are
poorly defined and arbitrary
representing “expert opinion”
only - Grade V level of
evidence.
Survey of CAPS membership on management of CPAM, especially
observation, In press 2018
Size of asymptomatic CPAM lesions at which Canadian pediatric
surgeons considered appropirate to observe
Complications of surgery for patients operated on
when becoming symptomatic
Longer hospital stay
Longer pleural drainage and invasive ventilation
Higher rate of postoperative complications
Fistula
Hemorrhage
Second surgery
No difference in mortality
Elective surgery, eliminating CPAM complications, is thus
considered to provide better outcome than emergency surgery.
Optimal timing for elective resection of asymptomatic
congenital pulmonary airway malformations Eric B. Jelin a,⁎, Elizabeth M. O'Hare a, Tim Jancelewicz b, Isam Nasr a,
Emily Boss c, Daniel S. Rhee a
In press, Journal of Pediatric Surgery 2018
Between 1 months and 2 years old
anesthetic and surgical risks decrease after the first months of life
OR time increases with age
Lung maintains the capacity to expand and develop until 4 years of
age allowing better compensation when early surgery
ASA >2 and prolonged OR time associated with complications
Procedure = Lobectomy
• Well tolerated
• Good long term
pulmonary capacity
• Complete resection
• Segmentectomy can be
performed in special
situation
–Lesion well demarcated and
can be visualied
–15% incomplete resection
Complications of lobectomy
Early
Bleeding
Infection
Injury to other thoracic organs
Air leak / bronchopleural fistula
Pain
Death
Late – if using open approach, without muscle-sparing
Chest wall deformity
Scoliosis
Winged scapula
Thoracoscopy
Slowly replacing thoracotomy
As safe, if not safer
More challenging for surgeon
and anesthetist
Better cosmetic results
Shorter LOS
Less pain and narcotic use
Similar OR time past learning
curve
Pulmonary capacity post lobectomy
All studies comparing pulmonary function test after
lobectomy in early life versus normal controls show no
statistical differences
Congenital lobar
emphysema
Who would observe
an asymptomatic
patient?
Congenital lobar emphysema
Resection for symptomatic patients
Asymptomatic patients can be observed
Easily followed with CXR
In 1976, study compared PFTs in patients who had surgery
(symptomatic) and children observed (asymptomatic or mild
symptoms)
Same results in both: diminished PFTs
Duplication cysts
Lined by enteric type mucosa
No cartilage
May contain ciliated epithelium
May extend in spinal canal
In the esophageal wall
Can cause dysphagia
Can contain gastric mucosa
bleeding
Malignant potential
Must be excised
Bronchogenic cyst
Resect even if
asymptomatic
VATS
Can be located in various
parts in the thorax
Follow up if no surgery
CT in first few months of life
Clinical follow-up after that if no change in
appearance
Surgery for
Symptoms
Parental wishes